| Descriptor English: | Bevacizumab | ||||||
| Descriptor Spanish: |
Bevacizumab
| ||||||
| Descriptor Portuguese: | Bevacizumab | ||||||
| Descriptor French: | Bévacizumab | ||||||
| Entry term(s): |
Avastin Bevacizumab awwb Bevacizumab-awwb Mvasi |
||||||
| Tree number(s): |
D12.776.124.486.485.114.224.060.375 D12.776.124.790.651.114.224.060.438 D12.776.377.715.548.114.224.200.438 |
||||||
| RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000068258 | ||||||
| Scope note: | An anti-VEGF humanized murine monoclonal antibody. It inhibits VEGF RECEPTORS and helps to prevent PATHOLOGIC ANGIOGENESIS. |
||||||
| Allowable Qualifiers: |
AD administration & dosage AE adverse effects AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification DE drug effects EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PK pharmacokinetics PO poisoning RE radiation effects TO toxicity TU therapeutic use UL ultrastructure UR urine |
||||||
| Pharm Action: |
Antineoplastic Agents, Immunological Angiogenesis Inhibitors |
||||||
| Registry Number: | 2S9ZZM9Q9V | ||||||
| Public MeSH Note: | 2016; BEVACIZUMAB was indexed under ANTIBODIES, MONOCLONAL, HUMANIZED 2012-2015, and under ANTIBODIES, MONOCLONAL 2002-2011 |
||||||
| History Note: | 2016 (2002) |
||||||
| Related: |
Receptors, Vascular Endothelial Growth Factor
MeSH | ||||||
| DeCS ID: | 55974 | ||||||
| Unique ID: | D000068258 | ||||||
| Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
| Date Established: | 2016/01/01 | ||||||
| Date of Entry: | 2015/07/10 | ||||||
| Revision Date: | 2018/11/02 |
-
-
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins
|
|
Bevacizumab
- Preferred
Mvasi
- Narrower
Bevacizumab-awwb
- Narrower
Avastin
- Narrower
| Concept UI |
M0443627 |
| Scope note | An anti-VEGF humanized murine monoclonal antibody. It inhibits VEGF RECEPTORS and helps to prevent PATHOLOGIC ANGIOGENESIS. |
| Preferred term | Bevacizumab |
| Concept UI |
M000638103 |
| Preferred term | Mvasi |
| Concept UI |
M000638602 |
| Preferred term | Bevacizumab-awwb |
| Entry term(s) |
Bevacizumab awwb |
| Concept UI |
M0446630 |
| Preferred term | Avastin |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey
